289 related articles for article (PubMed ID: 29309521)
21. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Gomes Silva BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2012 Oct; 10():CD008858. PubMed ID: 23076951
[TBL] [Abstract][Full Text] [Related]
22. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
23. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
[TBL] [Abstract][Full Text] [Related]
24. Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States.
Florea A; Sy L; Qian L; Ackerson B; Luo Y; Wu J; Cheng Y; Ku J; Vega Daily L; Takhar H; Song J; Chmielewski-Yee E; Spence O; Seifert H; Oraichi D; Tseng HF
Hum Vaccin Immunother; 2024 Dec; 20(1):2327145. PubMed ID: 38488143
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
[TBL] [Abstract][Full Text] [Related]
26. Preventing herpes zoster through vaccination: New developments.
Le P; Sabella C; Rothberg MB
Cleve Clin J Med; 2017 May; 84(5):359-366. PubMed ID: 28530894
[TBL] [Abstract][Full Text] [Related]
27. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study.
Sun Y; Jackson K; Dalmon CA; Shapiro BL; Nie S; Wong C; Arnold BF; Porco TC; Acharya NR
Vaccine; 2021 Jun; 39(29):3974-3982. PubMed ID: 34116874
[TBL] [Abstract][Full Text] [Related]
29. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
30. Zoster vaccine protects against shingles.
BMJ; 2013 Apr; 346():f2389. PubMed ID: 23596220
[No Abstract] [Full Text] [Related]
31. Shingles vaccine.
Willison CB; Morrison LK; Mendoza N; Tyring SK
Expert Opin Biol Ther; 2010 Apr; 10(4):631-8. PubMed ID: 20113211
[TBL] [Abstract][Full Text] [Related]
32. Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.
Le P; Rothberg MB
Am J Prev Med; 2017 Dec; 53(6):829-836. PubMed ID: 29153126
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease.
Tseng HF; Luo Y; Shi J; Sy LS; Tartof SY; Sim JJ; Hechter RC; Jacobsen SJ
Clin Infect Dis; 2016 Feb; 62(4):462-7. PubMed ID: 26671505
[TBL] [Abstract][Full Text] [Related]
34. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK
Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
Tseng HF; Smith N; Sy LS; Jacobsen SJ
Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
[TBL] [Abstract][Full Text] [Related]
36. Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
Draper M; Stergiopoulos S
Vaccine; 2021 Nov; 39(46):6781-6786. PubMed ID: 34625290
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of the Recombinant Zoster Vaccine in Adults Aged 50 and Older in the United States: A Claims-Based Cohort Study.
Sun Y; Kim E; Kong CL; Arnold BF; Porco TC; Acharya NR
Clin Infect Dis; 2021 Sep; 73(6):949-956. PubMed ID: 33580245
[TBL] [Abstract][Full Text] [Related]
38. Determinants of shingles vaccine acceptance in the United Kingdom.
Bricout H; Torcel-Pagnon L; Lecomte C; Almas MF; Matthews I; Lu X; Wheelock A; Sevdalis N
PLoS One; 2019; 14(8):e0220230. PubMed ID: 31369608
[TBL] [Abstract][Full Text] [Related]
39. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals.
Klaric JS; Beltran TA; McClenathan BM
Mil Med; 2019 Mar; 184(Suppl 1):126-132. PubMed ID: 30901393
[TBL] [Abstract][Full Text] [Related]
40. [The clinical and epidemic characteristics of shingles (herpes zoster) and its prevention with vaccines].
Afonina NM; Mikheeva IV
Ter Arkh; 2013; 85(11):130-3. PubMed ID: 24432613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
